LANA MEDICAL COMPANY Financials Lana Medical Company
Equities
9587
SA15TGFKLPH6
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.65 SAR | +0.43% |
|
+0.43% | +8.28% |
| 06-10 | Correction: Saudi Arabia's Lana Wins SAR21 Million Hazardous Medical Waste Deal | MT |
| 06-10 | Saudi Arabia's Lana Wins SAR21 Million Hazardous Medical Waste Deal | MT |
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Net sales 1 | 31.97 | 40.8 |
| EBITDA 1 | 8.088 | 7.535 |
| EBIT 1 | 7.319 | 6.523 |
| Operating Margin | 22.9% | 15.99% |
| Earnings before Tax (EBT) 1 | 7.791 | 6.62 |
| Net income 1 | 6.594 | 5.493 |
| Net margin | 20.63% | 13.46% |
| EPS 2 | 3.014 | 1.831 |
| Free Cash Flow | - | -1.798 |
| FCF margin | - | -4.41% |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 03/10/23 | 03/10/23 |
1SAR in Million2SAR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Net Debt 1 | 5.23 | 4.92 |
| Net Cash position 1 | - | - |
| Leverage (Debt/EBITDA) | 0.6462 x | 0.6528 x |
| Free Cash Flow | - | -1.8 |
| ROE (net income / shareholders' equity) | - | 12.3% |
| ROA (Net income/ Total Assets) | - | 6.77% |
| Assets 1 | - | 81.17 |
| Book Value Per Share 2 | 19.00 | 15.80 |
| Cash Flow per Share 2 | 1.610 | 1.100 |
| Capex 1 | 7.22 | 5.1 |
| Capex / Sales | 22.58% | 12.5% |
| Announcement Date | 03/10/23 | 03/10/23 |
1SAR in Million2SAR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +8.28% | 33.11M | |
| -11.16% | 8.61B | |
| -4.44% | 1.36B | |
| -11.94% | 1.3B | |
| -2.38% | 1.23B | |
| -30.35% | 729M | |
| -.--% | 615M | |
| +8.90% | 482M | |
| +2.83% | 437M | |
| -35.03% | 287M |
- Stock Market
- Equities
- 9587 Stock
- Financials Lana Medical Company
